"Currently, there are no approved therapies in regenerative medicine for heart failure, " said Karen Christman, assistant professor of bioengineering at the University of California, San Diego, who wasn't involved in the latest experiments.

WSJ: Nanotechnology Holds Promise for Heart Patients